相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 保存条件:
常温,避光
- 克隆性:
单克隆
- 抗体名:
PD-L1 / B7-H1 / CD274抗体
免疫原 : Recombinant Mouse PD-L1 / B7-H1 / CD274 protein (Catalog#50010-M08H)
Reagents : PE-conjugated rabbit monoclonal antibody
Clone ID : 485
抗体宿主 : Rabbit IgG
Concentration : 2 μl/Test, 0.1 mg/ml
缓冲液 : Aqueous solution containing 0.5% BSA and 0.09% sodium azide
制备方法 : This antibody was obtained from a rabbit immunized with purified, recombinant Mouse PD-L1 / B7-H1 / CD274 (rM PD-L1 / B7-H1 / CD274; Catalog#50010-M08H; NP_068693.1; Met1-Thr238) and conjugated with PE under optimum conditions, the unreacted PE was removed.
PD-L1 / B7-H1 / CD274抗体 Background
B7 homolog 1 (B7-H1), also called programmed death ligand 1 (PD-L1), is a member of the growing B7 family of immune molecules and is involved in the regulation of cellular and humoral immune responses. B7-H1 is a cell surface immunoglobulin superfamily with two Ig-like domains within the extracellular region and a short cytoplasmic domain. This protein is broadly expressed in the majority of peripheral tissues as well as hematopoietic cells. Interaction between B7-H1 and its receptors belonging to the CD28 family of molecules provide both stimulatory and inhibitory signals in regulating T cell activation and tolerance. As a costimulator, B7-H1 induces T-cell proliferation and preferentially the production of interleukin 10 and interferon gamma. Conversely, by binding to programmed death 1 receptors (PD-1) on activated T-cells and B-cells, B7-H1 may inhibit ongoing T-cell responses by inducing apoptosis and arresting cell-cycle progression. Accordingly, B7-H1 leads to growth of immunogenic tumor growth by increasing apoptosis of antigen specific T cells and may contribute to immune evasion by cancers. B7-H1 thus is regarded as promising therapeutic target for human autoimmune disease and malignant cancers.
PD-L1 / B7-H1 / CD274抗体相关产品如下:xy-0296xy-Axyxy Mouse IgG/APC荧光素APC标记小鼠IgG(细胞流式同型对照)
xy-0293xy-Axyxy Rat IgG/APC荧光素APC标记大鼠IgG(细胞流式同型对照)
xy-0326xy-Axyxy Bovine IgG/APC荧光素APC标记牛IgG
xy-0327xy-Axyxy Bovine IgM/APC荧光素APC标记牛IgM
xy-0310xy-Axyxy Chicken IgG/APC荧光素APC标记鸡IgG
xy-0314xy-Axyxy Chicken IgM/APC荧光素APC标记鸡IgM
xy-0303xy-Axyxy dog IgG/APC荧光素APC标记狗IgG
xy-0373xy-Axyxy dog IgM/APC荧光素APC标记狗IgM
xy-0370xy-Axyxy Goat IgM/APC荧光素APC标记羊IgM
xy-0358xy-Axyxy Guinea IgG/APC荧光素APC标记豚鼠IgG
xy-0375xy-Axyxy Guinea IgM/APC荧光素APC标记豚鼠IgM
xy-0308xy-Axyxy Horse IgG/APC荧光素APC标记马IgG
xy-0374xy-Axyxy Horse IgM/APC荧光素APC标记马IgM
xy-0297xy-Axyxy human IgG/APC荧光素APC标记人IgG
xy-0345xy-Axyxy human IgM/APC荧光素APC标记人IgM
xy-0360xy-Axyxy human IgA/APC荧光素APC标记人IgA
xy-0335xy-Axyxy Monkey IgG/APC荧光素APC标记猴IgG
xy-0336xy-Axyxy Monkey IgM/APC荧光素APC标记猴IgM
xy-0309xy-Axyxy pig IgG/APC荧光素APC标记猪IgG
xy-0346xy-Axyxy Rat IgM/APC荧光素APC标记大鼠IgM
xy-0789xy-Axyxy Insulin Protein /APC荧光素APC标记猪胰岛素蛋白
xy-xy0002-Axyxy KLH/APC荧光素APC标记血蓝蛋白
xy-0945xy-Axyxy HSA(Human sermu albumin)/APC荧光素APC标记人血白蛋白
xy-2179xy-Axyxy AACT/APC荧光素APC标记胰糜蛋白酶
xy-0437xy-xyy3 Streptavidin/Cy3荧光素Cy3标记链霉亲和素
xy-0312xy-xyy3 Avidin/Cy3荧光素Cy3标记亲合素
xy-0362xy-xyy3 Protein A/Cy3Cy3标记蛋白A
xy-0295xy-xyy3 Rabbit IgG/Cy3荧光素Cy3标记兔IgG(细胞流式同型对照)
xy-0296xy-xyy3 Mouse IgG/Cy3荧光素Cy3标记小鼠IgG(细胞流式同型对照)
xy-0294xy-xyy3 Goat IgG/Cy3荧光素Cy3标记羊IgG(细胞流式同型对照)
xy-0293xy-xyy3 Rat IgG/Cy3荧光素Cy3标记大鼠IgG(细胞流式同型对照)
xy-0326xy-xyy3 Bovine IgG/Cy3荧光素Cy3标记牛IgG
xy-0327xy-xyy3 Bovine IgM/Cy3荧光素Cy3标记牛IgM
xy-0310xy-xyy3 Chicken IgG/Cy3荧光素Cy3标记鸡IgG
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
文献和实验2 H1 :π1 ≠π2 α=0.05 2.计算理论数:(已完成列入四格表括弧中) 3.计算x2 值:应用公式(20.15)运算如下: 查x2 界值表,x2 0.05(1) =3.84,故x2 <x2 0.05(1) ,P>0.05. 按α=0.05水准,接受H0 ,两种疗效差异无统计学意义。 如果不采用校正公式,而用原基本公式,算得的结果x2 =4.068,则结论就不同
了 B7 家族的第三个成员 B7-H1(即日后的 PD-L1)[2]。2000 年,Tasuku Honjo 教授等人证明了 PD-L1 能与 PD-1 结合,进而抑制 T 细胞的增殖与细胞因子的分泌,负调控淋巴细胞的激活,从此,B7-H1 被正式命名为 PD-L1(陈列平教授则继续使用「B7-H1」命名)[3]。2003年,陈列平教授第一次成功地使用 PD-L1 封闭抗体联合 T 细胞回输技术治愈了约 60% 的头颈癌小鼠[4]。2014 年 12 月,首个应用于肿瘤治疗的抗 PD-1 抗体
人转录因子E2F1 ( E2F1 )ELISA 试剂盒 原理 本实验采用双抗体夹心 ABC-ELISA 法。用抗人 E2F1 单抗包被于酶标板上,标准品和样品中的 E2F1与单抗结合,加入生物素化的抗人 E2F1 ,形成免疫复合物连接在板上,辣根过氧化物酶标记的 Streptavidin 与生物素结合,加入底物工作液显蓝色,最后加终止液硫酸,在 450nm 处测 OD 值,E2F1 浓度与 OD 值成正比
技术资料暂无技术资料 索取技术资料




